China NMPA Drug Inspection - Anhui Yishengyuan Traditional Chinese Medicine Pieces Technology Co., Ltd. - Bai Ziren
China NMPA drug inspection for Anhui Yishengyuan Traditional Chinese Medicine Pieces Technology Co., Ltd. published November 24, 2017. Drug: Bai Ziren. The Shanghai Municipal Food and Drug Administration (SMFDA) issued its 2017 Issue 7 Drug Supervision and Sampling Qualit
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Anhui Yishengyuan Traditional Chinese Medicine Pieces Technology Co., Ltd. published November 24, 2017. Drug: Bai Ziren. The Shanghai Municipal Food and Drug Administration (SMFDA) issued its 2017 Issue 7 Drug Supervision and Sampling Qualit
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox